Jun 01, 2017 11:40 am UTC| Business
NEW YORK, June 01, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Jun 01, 2017 11:39 am UTC| Business
NEW YORK, June 01, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Jun 01, 2017 11:39 am UTC| Business
NEW YORK, June 01, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Jun 01, 2017 11:39 am UTC| Business
NEW YORK, June 01, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Jun 01, 2017 11:39 am UTC| Business
NEW YORK, June 01, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Spark Therapeutics to Participate in Multiple Conferences in June
Jun 01, 2017 11:38 am UTC| Business
PHILADELPHIA, June 01, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows